BIO Applauds SEC for Providing Regulatory Relief to Emerging Biotech Innovators

BIO Applauds SEC for Providing Regulatory Relief to Emerging Biotech Innovators


Jun 28, 2018--Biotechnology Innovation Organization President and CEO Jim Greenwood released the following statement regarding today's vote by the Securities and Exchange Commission : "I applaud the SEC for providing much-needed regulatory relief to small public companies. The broadened definition of 'smaller reporting company' will allow emerging biotech companies to spend more of their limited capital on lifesaving research, rather than unnecessary compliance costs.



from Biotech News